Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA Approves Birth Control Mobile App, Vaginal Ring

Executive Summary

US FDA announced the approval of the first direct-to-consumer mobile medical app that can prevent pregnancy via fertility awareness tracking. The app, Natural Cycles, has been criticized in Europe after some users experienced unplanned pregnancies. On the same day, the agency approved the first contraceptive vaginal ring that can be reused for an entire year.

You may also be interested in...

Birth Control App Cleared For Use On Consumer Wearable Devices

The Natural Cycles app, which uses fertility tracking to prevent pregnancy, is the first contraceptive cleared for use on the devices.

Maker Of First OTC Birth Control App Approved In US Questions Clearance Of Competitor's Product

FDA cleared Clue as second OTC app with a birth control indication to reach market but the company making the first app the agency cleared questions whether Clue is as effective and says a more extensive evaluation of Clue is needed.

Clue Faces Competitor Scrutiny On Entry Into Birth Control App Space

The US Food and Drug Administration has cleared Clue as the second app with a birth control indication to reach market – but the first company on the scene questions whether it's as effective as theirs.

Related Content


Related Companies

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts